Kelonia Therapeutics snags $50m Series A
Kelonia Therapeutics, a biotech company, has secured $50 million in Series A financing.
Kelonia Therapeutics, a biotech company, has secured $50 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination